Abstract
Aim:
This
study investigated the efficiency of BiVO4 nanoparticles (BiVO4
NPs) against drug-resistant bacteria, Acinetobacter baumannii and
Methicillin-resistant Staphylococcus aureus (MRSA).
Methodology: The study
employed a multifaceted approach, evaluating the ablity of BiVO4
NPs to inhibit bacterial growth, reduce viable cell counts over time, and
hinder biofilm formation. Furthermore, the investigation explored the NPs
impact on virulence factors using protease and hemolysin inhibition assays.
Results: The findings
showed the potent efficacy of BiVO4 NPs against A. baumannii
and MRSA. Notable results included the formation of clear inhibition zones up
to 19 and 15 mm, indicating the antimicrobial activity against both
pathogens. BiVO4 NPs also effectively inhibited biofilm formation,
reduced bacterial adherence, and inhibited virulence factors, underscoring
their potential as effective agents against drug-resistant bacteria and
suggesting promising applications in medical implants and anti-microbial
research.
Interpretation: Overall, this
study provides compelling evidence supporting the potential use of BiVO4
Nps as an antimicrobial agent and a promising candidate for addressing
various human health concerns.
Key
words:
Antimicrobial, Antibiofilm, Anti-adhesive, Bismuth vanadate, Nanoparticles
|